BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36622431)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
    Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China.
    Liu J; Wu XW; Li T; Hao XW; Duan YH; Zhao J; Zhu CZ; Wei B; Dong Q
    Pediatr Hematol Oncol; 2021 May; 38(4):319-330. PubMed ID: 33667139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staged resection for a ruptured hepatoblastoma: a 6-year follow-up.
    Madanur MA; Battula N; Davenport M; Dhawan A; Rela M
    Pediatr Surg Int; 2007 Jun; 23(6):609-11. PubMed ID: 17066271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical resection of chemotherapy-insensitive pulmonary metastases in children with hepatoblastoma in China: A single-center experience.
    Xie H; Liu G; Shen Z; Xing G; Xia Q; Wang X; Huang L
    J Cancer Res Ther; 2022 Sep; 18(5):1387-1391. PubMed ID: 36204887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J;
    Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
    Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
    JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study.
    Zhang Y; Zhang WL; Huang DS; Hong L; Wang YZ; Zhu X; Hu HM; Zhang PW; Yi Y; Han T
    Asian Pac J Cancer Prev; 2013; 14(8):4583-9. PubMed ID: 24083706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: A single institution experience.
    Hou JY; Yeh TC; Huang TH; Sheu JC; Liu HC
    Pediatr Neonatol; 2021 Jul; 62(4):400-405. PubMed ID: 33967009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
    Espinoza AF; Patel KR; Shetty PB; Whitlock RS; Sumazin P; Yu X; Sarabia SF; Urbicain M; Heczey A; Masand P; Woodfield SE; López-Terrada DH; Vasudevan SA
    Cancer Med; 2023 Dec; 12(23):21270-21278. PubMed ID: 37962078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study.
    Yang W; Chen Y; Huang Y; Wang H
    BMC Pediatr; 2019 Dec; 19(1):485. PubMed ID: 31822277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of preoperative transcatheter arterial chemoembolization combined with systemic chemotherapy for treatment of unresectable hepatoblastoma in children.
    Hirakawa M; Nishie A; Asayama Y; Fujita N; Ishigami K; Tajiri T; Taguchi T; Honda H
    Jpn J Radiol; 2014 Sep; 32(9):529-36. PubMed ID: 24923584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective Analysis of Pediatric Hepatoblastoma With Tumor Rupture: Experience From a Single Center.
    Zhang YT; Zhao YF; Yang DF; Chang J
    Front Pediatr; 2022; 10():799307. PubMed ID: 35391745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
    Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
    J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
    Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effect and clinical cost of multi-disciplinary team model of hepatoblastoma in children].
    Gao YX; Sun Q; Li H; Xie Y; Yao HX; Zhao WH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):200-203. PubMed ID: 33550357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.